The overlooked danger: Lack of drug testing in obese individuals

Drugs are rarely tested in people who are obese, despite the fact that over 40% of American adults are considered obese. Clinical trials often exclude obese individuals, leading to a lack of understanding about how medications work in bigger bodies. This can have serious consequences, as drugs may not be effective or may cause harmful interactions in obese patients. The U.S. Food and Drug Administration and the National Institutes of Health are recognizing the need for more research in this area, but progress is slow. In the meantime, patients are encouraged to discuss appropriate dosing with their doctors and advocate for better representation in drug studies.